OVAS

Several Biotech Stocks Indicating A Macro Short Strategy | Seeking …

SummaryOvaScience, Sarpeta Therapeutics, Ziopharm Oncology and Keryx Biopharmaceuticals all have a short interest above 20%.
These small cap biotech companies provide attractive characteristics for fundamental weakness through liquidity needs, no revenue and a higher fail rate.
Given these common variables, there is strong indication that a large Marco short strategy has been put in place.
This large short position provides opportunities for contrarian […]

Scanning For Extreme Momentum Burst Pull Backs

Short term momentum extremes over a month period tend to mean revert. A recent example of this is CUBA which went parabolic with gains in excess of 100% over a 4 day period. Another example from last September/October is LAKE which gained nearly 400% over month.
CUBA

LAKE

One approach to these types of extreme moves is to devise tactics for shorting, particularly […]

OvaScience Reports First Quarter 2014 Financial Results

[Business Wire] – OvaScienceSM, , a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, today reported first quarter 20 moreView todays social media effects on OVASView the latest stocks trending across Twitter. Click to view dashboardSee who OvaScience is hiring next, click here to view […]

8:35 am OvaScience announced the pricing of $10.00/share for its previously announced underwritten public offering of 5,000,000 shares of its common stock

moreView todays social media effects on OVASView the latest stocks trending across Twitter. Click to view dashboardSee who OvaScience is hiring next, click here to view […]

OvaScience Reports Fourth Quarter and Year End 2013 Financial Results

[Business Wire] – OvaScienceSM, , a global life sciences company focused on the discovery, development and commercialization of new fertility treatments, today reported fourth quarter moreView todays social media effects on OVASView the latest stocks trending across Twitter. Click to view dashboardSee who OvaScience is hiring next, click here to view […]